Laura Brown believes no one has to live with chronic pain.
Laura is dually licensed as a physical and massage therapist with her own practice in Schenectady. Twenty-three years in practice, she is very excited to add Calmare Therapy to her arsenal.
“I have spent two years researching and readying my practice for Calmare,” Brown said. “This is a game-changer for people suffering with neuropathic pain. It is non-invasive and drug-free, making it the perfect alternative for opioids.”
This device, US FDA 510(k) cleared, uses a biophysical, rather than a biochemical, approach. It gives therapists the ability to simultaneously treat multiple areas of the body by applying surface electrodes directly to the skin. Calmare® then produces a no-pain signal, which becomes the dominant signal to the brain, overriding the sensation of pain.
With over 4,000 patients successfully treated worldwide, it has proven effective for neurological and oncologic pain. Compatible diagnoses include chemotherapy-induced peripheral neuropathy, phantom limb syndrome, sciatica, low back pain, postherpetic neuralgia and chronic regional pain syndrome, among others.
For those wanting more information, Brown suggests visiting her website. Key factors to successful treatment with Calmare include a proper diagnosis from a neurologist or pain management physician, communication with the referring physician with regards to medication weaning and strict adherence to the treatment protocol.
“Calmare is an accretive treatment,” Brown said. “While patients should know within a couple of treatment sessions if it is working, consistent sessions daily are required until the new baseline of pain is reached.”
Brown stated, “This is a wonderful and effective treatment for those who suffer chronic pain. Most have tried everything and are still suffering. This has worked where other treatments have not. I highly recommend looking into this treatment. To top it all off, it isn’t even noxious. Many people fall asleep having their first relief-experience in a long time.”
